A Tech-Startup and a GI Giant Just Redefined Clinical Research
What happens when the largest GI practice in the country partners with a digital-native startup?
You get more than scale. You get a radical redesign of how clinical research works—where trials no longer live on the sidelines of care, but at its very center.
On The Scope Forward Show, Dr. Jonathan Ng (Founder & CEO, Iterative Health) and Dr. Casey Chapman (CMO, GI Alliance) announced a first-of-its-kind alliance:
→ 80 research sites across the globe
→ A shared platform for trial execution at the point of care
→ And a vision to restore agency to physicians while unlocking equitable access for patients
“It’s not about trial volume. It’s about raising the standard of care through research.”
– Dr. Jonathan Ng
“If this was just about ROI, we wouldn’t be here. This is about building the future—with physicians, for patients.”
– Dr. Casey Chapman
This isn’t a financial partnership. It’s a systemic intervention—two years in the making—that breaks through recruitment bottlenecks, removes operational friction, and makes GI a launchpad for drug innovation.
I'm excited about this announcement because it signals a shift not just for the organizations involved but for GI at large.
Top 10 Highlights:
